215 related articles for article (PubMed ID: 29499713)
1. Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes.
Zhuo H; Zheng B; Liu J; Huang Y; Wang H; Zheng D; Mao N; Meng J; Zhou S; Zhong L; Zhao Y
J Exp Clin Cancer Res; 2018 Mar; 37(1):42. PubMed ID: 29499713
[TBL] [Abstract][Full Text] [Related]
2. Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles.
Zhou Y; Gu H; Xu Y; Li F; Kuang S; Wang Z; Zhou X; Ma H; Li P; Zheng Y; Ran H; Jian J; Zhao Y; Song W; Wang Q; Wang D
Theranostics; 2015; 5(4):399-417. PubMed ID: 25699099
[TBL] [Abstract][Full Text] [Related]
3. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
4. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.
Eloy JO; Petrilli R; Chesca DL; Saggioro FP; Lee RJ; Marchetti JM
Eur J Pharm Biopharm; 2017 Jun; 115():159-167. PubMed ID: 28257810
[TBL] [Abstract][Full Text] [Related]
5. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
[TBL] [Abstract][Full Text] [Related]
6. Tumor imaging and interferon-γ-inducible protein-10 gene transfer using a highly efficient transferrin-conjugated liposome system in mice.
Zhuo H; Peng Y; Yao Q; Zhou N; Zhou S; He J; Fang Y; Li X; Jin H; Lu X; Zhao Y
Clin Cancer Res; 2013 Aug; 19(15):4206-17. PubMed ID: 23759675
[TBL] [Abstract][Full Text] [Related]
7. Bispecific single-chain diabody-immunoliposomes targeting endoglin (CD105) and fibroblast activation protein (FAP) simultaneously.
Rabenhold M; Steiniger F; Fahr A; Kontermann RE; Rüger R
J Control Release; 2015 Mar; 201():56-67. PubMed ID: 25617725
[TBL] [Abstract][Full Text] [Related]
8. Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice.
Zheng AQ; Song XR; Yu JM; Wei L; Wang XW
World J Gastroenterol; 2005 Jul; 11(28):4439-42. PubMed ID: 16038050
[TBL] [Abstract][Full Text] [Related]
9. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
[TBL] [Abstract][Full Text] [Related]
10. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
Kirpotin DB; Drummond DC; Shao Y; Shalaby MR; Hong K; Nielsen UB; Marks JD; Benz CC; Park JW
Cancer Res; 2006 Jul; 66(13):6732-40. PubMed ID: 16818648
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
12. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
Shi C; Cao H; He W; Gao F; Liu Y; Yin L
Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
[TBL] [Abstract][Full Text] [Related]
13. Endoglin based in vivo near-infrared fluorescence imaging of tumor models in mice using activatable liposomes.
Tansi FL; Rüger R; Kollmeier AM; Rabenhold M; Steiniger F; Kontermann RE; Teichgraeber UK; Fahr A; Hilger I
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1389-1400. PubMed ID: 29545133
[TBL] [Abstract][Full Text] [Related]
14. Mc-hES, a novel plasmid carrying human endostatin gene, inhibits nasopharyngeal carcinoma growth.
Xu BL; Yuan L; Wu JX; Xu N; Fang WJ; Zhao P; Huang WL
Cancer Gene Ther; 2012 Feb; 19(2):110-7. PubMed ID: 22158523
[TBL] [Abstract][Full Text] [Related]
15. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.
Nässander UK; Steerenberg PA; Poppe H; Storm G; Poels LG; De Jong WH; Crommelin DJ
Cancer Res; 1992 Feb; 52(3):646-53. PubMed ID: 1732053
[TBL] [Abstract][Full Text] [Related]
16. Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
Vingerhoeds MH; Steerenberg PA; Hendriks JJ; Dekker LC; Van Hoesel QG; Crommelin DJ; Storm G
Br J Cancer; 1996 Oct; 74(7):1023-9. PubMed ID: 8855969
[TBL] [Abstract][Full Text] [Related]
17. Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes.
Kim KS; Lee YK; Kim JS; Koo KH; Hong HJ; Park YS
Cancer Gene Ther; 2008 May; 15(5):331-40. PubMed ID: 18309354
[TBL] [Abstract][Full Text] [Related]
18. Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).
Völkel T; Hölig P; Merdan T; Müller R; Kontermann RE
Biochim Biophys Acta; 2004 May; 1663(1-2):158-66. PubMed ID: 15157618
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW
Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174
[TBL] [Abstract][Full Text] [Related]
20. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
Koning GA; Kamps JA; Scherphof GL
Cancer Detect Prev; 2002; 26(4):299-307. PubMed ID: 12430634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
